PL3097909T3 - Mikrocząstki możliwe do podawania in vivo przez przewód medyczny - Google Patents

Mikrocząstki możliwe do podawania in vivo przez przewód medyczny

Info

Publication number
PL3097909T3
PL3097909T3 PL15740074T PL15740074T PL3097909T3 PL 3097909 T3 PL3097909 T3 PL 3097909T3 PL 15740074 T PL15740074 T PL 15740074T PL 15740074 T PL15740074 T PL 15740074T PL 3097909 T3 PL3097909 T3 PL 3097909T3
Authority
PL
Poland
Prior art keywords
vivo
medical conduit
administrable
microparticles
administrable microparticles
Prior art date
Application number
PL15740074T
Other languages
English (en)
Inventor
Eunhye Lee
Keun Su Kim
Don Haeng Lee
Young Hwan Park
Original Assignee
Nextbiomedical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nextbiomedical Co., Ltd. filed Critical Nextbiomedical Co., Ltd.
Publication of PL3097909T3 publication Critical patent/PL3097909T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
PL15740074T 2014-01-21 2015-01-21 Mikrocząstki możliwe do podawania in vivo przez przewód medyczny PL3097909T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020140007089A KR101864465B1 (ko) 2014-01-21 2014-01-21 의료용 도관을 통한 생체 내 투여성 마이크로 입자
PCT/KR2015/000630 WO2015111914A1 (ko) 2014-01-21 2015-01-21 의료용 도관을 통한 생체 내 투여성 마이크로 입자
EP15740074.8A EP3097909B1 (en) 2014-01-21 2015-01-21 Administrable microparticles in vivo through medical conduit

Publications (1)

Publication Number Publication Date
PL3097909T3 true PL3097909T3 (pl) 2021-01-25

Family

ID=53681663

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15740074T PL3097909T3 (pl) 2014-01-21 2015-01-21 Mikrocząstki możliwe do podawania in vivo przez przewód medyczny

Country Status (9)

Country Link
US (1) US10004690B2 (pl)
EP (1) EP3097909B1 (pl)
JP (1) JP6306198B2 (pl)
KR (1) KR101864465B1 (pl)
CN (1) CN105934242B (pl)
ES (1) ES2833001T3 (pl)
PL (1) PL3097909T3 (pl)
PT (1) PT3097909T (pl)
WO (1) WO2015111914A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10441761B2 (en) 2016-07-01 2019-10-15 Boston Scientific Scimed, Inc. Delivery devices and methods
EP3568179B1 (en) 2017-01-10 2021-10-27 Boston Scientific Scimed, Inc. Apparatuses for delivering powdered agents
CN121944198A (zh) 2018-01-12 2026-05-01 波士顿科学国际有限公司 实现止血的粉末
US11766546B2 (en) 2018-01-31 2023-09-26 Boston Scientific Scimed, Inc. Apparatuses and methods for delivering powdered agents
KR20250092279A (ko) 2018-10-02 2025-06-23 보스톤 싸이엔티픽 싸이메드 인코포레이티드 분말 제제를 유동화 및 전달하기 위한 디바이스
EP3833423B1 (en) 2018-10-02 2025-04-30 Boston Scientific Scimed, Inc. Devices for fluidization and delivering a powdered agent
EP4578478A3 (en) 2019-12-03 2025-12-31 Boston Scientific Scimed Inc. MEDICAL DEVICE FOR AGENT ADMINISTRATION
US11931003B2 (en) 2019-12-03 2024-03-19 Boston Scientific Scimed, Inc. Medical devices for agent delivery and related methods of use
EP4545121A3 (en) 2019-12-03 2025-07-16 Boston Scientific Scimed, Inc. Devices for delivering powdered agents
CN121512581A (zh) 2019-12-03 2026-02-13 波士顿科学国际有限公司 用于药物输送的医疗装置及相关使用方法
CN114845644B (zh) 2019-12-20 2026-03-06 波士顿科学国际有限公司 药剂输送装置
EP4041094A1 (en) 2020-01-06 2022-08-17 Boston Scientific Scimed, Inc. Agent delivery systems
CN119971275A (zh) 2020-01-06 2025-05-13 波士顿科学国际有限公司 用于输送粉末状药剂的装置
US12083216B2 (en) 2020-02-18 2024-09-10 Boston Scientific Scimed, Inc. Hemostatic compositions and related methods
CN115243624A (zh) 2020-03-06 2022-10-25 波士顿科学国际有限公司 用于输送粉末状药剂的装置
CA3175862A1 (en) 2020-03-24 2021-09-30 Boston Scientific Scimed, Inc. Agent delivery systems and methods of using the same
CN121081715A (zh) 2020-04-17 2025-12-09 波士顿科学国际有限公司 止血组合物及相关方法
CN116171177A (zh) 2020-08-19 2023-05-26 波士顿科学国际有限公司 输送装置及其使用方法
WO2024015888A1 (en) 2022-07-14 2024-01-18 Boston Scientific Scimed, Inc. Valve assembly for a device for delivering agents

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10306160A (ja) 1997-05-08 1998-11-17 Chisso Corp 低含水率ε−ポリリジンの製造方法
EP2060253A1 (en) 2007-11-14 2009-05-20 Laboratorios Farmaceuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
US20040121003A1 (en) 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
AR054637A1 (es) 2004-01-30 2007-07-11 Ferrosan As Aerosoles y composiciones hemostaticas
JP4439517B2 (ja) 2004-05-13 2010-03-24 株式会社ネクスト21 経内視鏡手術に用いる止血と、癒着の防止装置
KR20060040329A (ko) * 2004-11-05 2006-05-10 나건 내시경을 통하여 도포 가능한 체내 지혈제 및 그 도포 방법
JP5223182B2 (ja) * 2005-10-27 2013-06-26 東レ株式会社 生分解性粒子およびその製造方法
CN104888264B (zh) * 2008-01-14 2018-01-09 北京环球利康科技有限公司 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料
WO2009113512A1 (ja) 2008-03-11 2009-09-17 キユーピー株式会社 Socs3発現促進剤、これを含有する医薬品および食品、ならびにsocs3の発現を促進する方法
AU2009232000B2 (en) * 2008-04-03 2014-12-11 Baxter International Inc. Hemostatic microspheres
US8653319B2 (en) * 2008-04-24 2014-02-18 Medtronic, Inc. Cold ionizing radiation sterilization
US9119897B2 (en) * 2009-05-28 2015-09-01 Profibrix B.V. Dry powder fibrin sealant
CN101862469B (zh) * 2010-05-28 2013-03-13 武汉人福医疗用品有限公司 一种壳聚糖衍生物快速止血颗粒及其制备方法
GB201021881D0 (en) * 2010-12-23 2011-02-02 Profibrix Bv Powder delivery device
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
US20130096082A1 (en) * 2011-10-11 2013-04-18 Baxter Healthcare S.A. Hemostatic compositions

Also Published As

Publication number Publication date
US20160367482A1 (en) 2016-12-22
EP3097909A4 (en) 2017-06-28
PT3097909T (pt) 2020-11-25
CN105934242B (zh) 2019-11-05
EP3097909B1 (en) 2020-10-21
JP2017503819A (ja) 2017-02-02
JP6306198B2 (ja) 2018-04-04
WO2015111914A1 (ko) 2015-07-30
CN105934242A (zh) 2016-09-07
KR20150086898A (ko) 2015-07-29
ES2833001T3 (es) 2021-06-14
KR101864465B1 (ko) 2018-06-04
EP3097909A1 (en) 2016-11-30
US10004690B2 (en) 2018-06-26

Similar Documents

Publication Publication Date Title
PT3097909T (pt) Micropartículas administráveis in vivo através de tubo médico
IL250685A0 (en) Medicinal substance induces cytotoxicity
PL3192451T3 (pl) Hak medyczny
SG11201703928QA (en) Patient interface
SG11201700489WA (en) Breast pump system and methods
SG11201700370YA (en) Breast pump system and methods
AU358462S (en) Patient interface
IL247072A0 (en) Medical use
HUE051354T2 (hu) Terapeutikum
PL3193995T3 (pl) Interfejs do współpracowania z pacjentem
AU363953S (en) Curved tissue fastening device
EP3389593C0 (en) MEDICAL DELIVERY DEVICE
GB201413357D0 (en) Antibodies for treatment and diagnosis
HUE065894T2 (hu) Bõrre rögzíthetõ orvostechnikai eszköz
SG11201701035SA (en) Cancer diagnosis and therapy
IL251905A0 (en) Epilimod for use in the treatment of kidney cancer
GB201410816D0 (en) Therapeutic agents
GB201410216D0 (en) Therapeutic
GB201410815D0 (en) Therapeutic agents
SG11201608284XA (en) Medical imaging
GB201410817D0 (en) Therapeutic agents
GB201403032D0 (en) Medical device
GB201510637D0 (en) Therapeutic
PL2995730T3 (pl) Odpływ podłogowy z lejkiem wlotowym
GB201401806D0 (en) Novel methods for diagnosis and therapy